Interview with Angela Trismitro , President Director, Dos Ni Roha
Which are the main transformations Dos Ni Roha has undergone in recent years? Dos Ni Roha has successfully taken advantage of its wide expertise in the Indonesian market ? based…
Address: -7/F Mugi Griya, Jl. Letjen M T Haryono Kav 10,Jakarta,Indonesia
Tel: 62 021 830 8494
Web: http://www.dosniroha.com/
The company is in business for more than 36 years. It currently markets and distributes leading brands for over 45 major principals from around the world.Our Products are distributed nationwide through our Distribution Points in 42 cities, reaching hundred thousands of outlets throughout the archipelago.Covering types of outlet such as : pharmacies, drugstores, hospitals, clinics, midwives, goverment institutions, hypermarkets, supermarkets, minimarkets, groceries, etc.The company combines sound management practice with solid financials foundation to provide reliable distribution and timely payments to principals.
Which are the main transformations Dos Ni Roha has undergone in recent years? Dos Ni Roha has successfully taken advantage of its wide expertise in the Indonesian market ? based…
The development of the Local Pharmaceutical industry companies has gone through rough times, competing from the very beginning with MNCs and going through the economic shock in the 90’s. In…
Local firms have assumed an increasing role in the Indonesian pharmaceutical market representing today more than 75% of the market share and being able to provide over 90% of the…
How challenging is it being for you to adapt to the Indonesian business mindset. My adaptation to Indonesia has been relatively smooth thanks to my past experience in different Asian…
For the last six years Soho Group has been the fastest growing pharmaceutical company in Indonesia, able to position itself among the top players in the industry. What have been…
After 20 years experience with Boehringer Ingelheim, what would you say are the main specificities of the Indonesian pharmaceutical industry? Indonesia differs some what from other Asian countries, starting from…
IDS Distribution is part of an Asian, globe spanning Distribution Company. How does being part of a large, regionally specialized player help IDS Distribution in Indonesia? The company’s regional presence…
Although Indonesia in the last ten years had the second highest growth in ASIA in terms of drugs’ production and consumption, the market share of research based companies has dropped…
The Indonesian Pharmaceutical industry has always held tremendous potential. Yet, somehow, over the past decades, the local industry was quickly dwarfed by regional powerhouses India and China, and even surpassed…
Since the installation of Mr. Fred Hassan in 2003, Schering-Plough has been oriented toward changes. At two years from your arrival you have been able to achieve IDR 170 billion…
See our Cookie Privacy Policy Here